These results indicate that STZ-induced diabetes disrupts the BM microenvironment and hematopoietic development by decreasing the expression of several key ligands, such as SDF-1, Ang1, and β-catenin in the BM. The gene discussed is ANGPT1; the disease is diabetes mellitus.